The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof: [Formula I] Where m, n, X, R 1 , R 2 , R 3 , R 4 and R 5 are as defined herein. The present invention also discloses methods and uses for the preparation of compounds for the treatment of diseases associated with the LRRK2 receptor, such as Parkinson's disease.
展开▼